Core Points - Emergent BioSolutions Inc. will be added to the Russell 3000 Index effective after the U.S. market closes on June 27, 2025, as part of the annual reconstitution of the Russell U.S. stock indexes [1][2] - The inclusion in the Russell 3000 Index is seen as a significant milestone in the company's transformation, indicating positive momentum and positioning for sustainable growth [2] - The Russell U.S. Indexes reconstitution captures the 4,000 largest U.S. stocks ranked by total market capitalization, with membership in the Russell 3000 Index providing automatic inclusion in either the large-cap Russell 1000 Index or small-cap Russell 2000 Index [2] Company Overview - Emergent BioSolutions has been focused on delivering protective and life-saving solutions for various health threats for over 25 years, including smallpox, mpox, botulism, Ebola, anthrax, and opioid overdose emergencies [5] - The company emphasizes its commitment to strong execution, financial stability, and long-term value creation for shareholders [2] Industry Context - Russell indexes are widely utilized by investment managers and institutional investors for index funds and as benchmarks for active investment strategies, with approximately $10.5 trillion in assets benchmarked against the Russell U.S. indexes as of December 2023 [3]